SIGN IN
Email Address
Password

Forgot password?
REGISTER HERE >>

Acute Coronary Syndrome Journal Club

According to the Journal of the American Medical Association, a physician would need to read nearly 20 articles per day, 365 days a year, to maintain current knowledge in general internal medicine. To help, the Acute Coronary Syndrome (ACS) Journal Club summarizes and synthesizes key scientific advances and clinical lessons from the literature, and offers commentary and insight from recognized ACS experts, who explain the implications of the latest research and clinical trials for day-to-day patient care.


Intervention & Prevention: Keeping Current with Acute Coronary Syndrome Journal Club (Issue #17)

2.00 / AMA PRA Category 1 Credit(s)TM
Articles of note: the use of CT angiography in evaluating patients; ticagrelor vs. clopidogrel in patients; issues relating to discontinuing antiplatelet therapy before CABG; strategies to reduce in-hospital AMI mortality; methods of managing post-PCI thrombosis; and CV deaths and azithromycin.
 

Intervention & Prevention: Keeping Current with Acute Coronary Syndrome Journal Club (Issue #16)

2.00 / AMA PRA Category 1 Credit(s)TM
Articles of note reviewed by our cardiology experts address the pros and cons of vorapaxar in secondary prevention of atherothrombotic events and more.
 

Intervention & Prevention: Keeping Current with Acute Coronary Syndrome Journal Club (Issue #15)

2.00 / AMA PRA Category 1 Credit(s)TM
Adding rivaroxaban to antiplatelet therapy post-ACS; vorapaxar in dual antiplatelet therapy; improving post-MI medication adherence; and more.
 

Intervention & Prevention: Keeping Current with Acute Coronary Syndrome Journal Club (Issue #14)

2.00 / AMA PRA Category 1 Credit(s)TM
Ticagrelor compared with clopidogrel; apixaban versus warfarin; platelet reactivity and cardiovasular outcomes after PCI; and more.
 

Intervention & Prevention: Keeping Current with Acute Coronary Syndrome Journal Club (Issue #13)

2.00 / AMA PRA Category 1 Credit(s)TM
The benefits of transcatheter versus surgical aortic-valve replacement in high-risk patients; the effects of post-PCI cardio rehabilitation on mortality; and more.
 

Intervention & Prevention: Keeping Current with Acute Coronary Syndrome - Journal Club (Issue #12)

2.00 / AMA PRA Category 1 Credit(s)TM
Top cardiologists interpret the GRAVITAS trial, cardiorespiratory fitness as CV risk classification, triple antiplatelet therapy, and results from the PLATO study.
 

Intervention & Prevention: Keeping Current with Acute Coronary Syndrome - Journal Club (Issue #11)

2.00 / AMA PRA Category 1 Credit(s)TM
Our experts weigh in on using clopidogrel with omeprazole; switching from clopidogrel to prasugrel in ACS patients; and determining risk from atherosclerotic plaques.
 

Intervention & Prevention: Keeping Current with Acute Coronary Syndrome - Journal Club (Issue #10)

2.00 / AMA PRA Category 1 Credit(s)TM
Therapy for ACS utilizes a combination of surgical interventions and pharmacotherapy, with antiplatelet agents playing an essential role.
 

Intervention & Prevention: Keeping Current with Acute Coronary Syndrome - Journal Club (Issue #9)

2.00 / AMA PRA Category 1 Credit(s)TM
Therapy for ACS utilizes a combination of surgical interventions (including percutaneous coronary interventions [PCI]) and pharmacotherapy, with antiplatelet agents playing an essential role.
 

Intervention & Prevention: Keeping Current with Acute Coronary Syndrome - Journal Club (Issue #8)

2.00 / AMA PRA Category 1 Credit(s)TM
Therapy for ACS utilizes a combination of surgical interventions (including percutaneous coronary interventions [PCI]) and pharmacotherapy, with antiplatelet agents playing an essential role. There may be significant risks with these interventions, during the procedure itself and in the months and years following.
 

Intervention & Prevention: Keeping Current with Acute Coronary Syndrome - Journal Club (Issue #7)

2.00 / AMA PRA Category 1 Credit(s)TM
Therapy for ACS utilizes a combination of surgical interventions (including percutaneous coronary interventions [PCI]) and pharmacotherapy, with antiplatelet agents playing an essential role.
 

Intervention & Prevention: Keeping Current with Acute Coronary Syndrome - Journal Club (Issue #6)

2.00 / AMA PRA Category 1 Credit(s)TM
Therapy for ACS utilizes a combination of surgical interventions (including percutaneous coronary interventions [PCI]) and pharmacotherapy, with antiplatelet agents playing an essential role.
 

Intervention & Prevention: Keeping Current with Acute Coronary Syndrome - Journal Club (Issue #5)

2.00 / AMA PRA Category 1 Credit(s)TM
This activity is part of the Acute Coronary Syndrome Journal Club series, which provides clinicians with in-depth synopses of recently published, peer-reviewed studies on cardiovascular medicine.
 

Intervention & Prevention: Keeping Current with Acute Coronary Syndrome - Journal Club (Issue #4)

2.00 / AMA PRA Category 1 Credit(s)TM
Management of ACS utilizes a combination of surgical interventions and pharmacotherapy, with antiplatelet agents playing an essential role.
 

Intervention & Prevention: Keeping Current with Acute Coronary Syndrome - Journal Club (Issue #2)

2.00 / AMA PRA Category 1 Credit(s)TM
This activity is part of the Acute Coronary Syndrome Journal Club series, which provides clinicians with in-depth synopses of recently published, peer-reviewed studies on cardiovascular medicine.
 

NEW DRUG CME FROM MPR

New Drug Approvals

     
    Exclusively from myCME.com and the editors of MPR. 
     
  • Learn about the newest drug approvals and uses while earning CME/CE credit

Home | Browse By Disease | Browse By Specialty | Browse By Profession | About HME | Contact Us | Web Support

© 2013 Haymarket Media, Inc.

Your use of this website constitutes acceptance of Haymarket Medical Education's Privacy Policy and Terms & Conditions

Haymarket Medical Education